Therapeutic targeting of MLL degradation pathways in MLL-rearranged leukemia

Liang, KW; Volk, AG; Haug, JS; Marshall, SA; Woodfin, AR; Bartom, ET; Gilmore, JM; Florens, L; Washburn, MP; Sullivan, KD; Espinosa, JM; Cannova, J; Zhang, JW; Smith, ER; Crispino, JD; Shilatifard, A

FASEB JOURNAL, 2017; 31 ( ):